Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives

Fig. 5

Treatment of nanomaterials in LN. In the treatment of LN, a nanodrug delivery system can target the kidney and form an immune complex. LN  lupus nephritis; CsA  cyclosporine A, TAC  tacrolimus, PDA  polydopamine, PEG  polyethylene glycol, HPMA  P-Dex9 (N-(2-hydroxypropyl) methacrylamide, TWHF  tripterygium wilfordii, ImM  imatinib mesylate, PCL  polyethylene glycol cationic liposome

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us